Patent details

EN | LT

LT - ADENOVIRUS WITH MUTATIONS IN THE ENDOPLASMIC RETICULUM RETENTION DOMAIN OF THE E3-19K PROTEIN AND THEIR USE IN CANCER TREATMENT.

EN - ADENOVIRUS WITH MUTATIONS IN THE ENDOPLASMIC RETICULUM RETENTION DOMAIN OF THE E3-19K PROTEIN AND THEIR USE IN CANCER TREATMENT.

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C12N 7/01
		A61K 35/76

European patent
(11)	Number of the document	2137301
(13)	Kind of document	T
(96)	European patent application number	08735417.1
	Date of filing the European patent application	2008-03-12
(97)	Date of publication of the European application	2009-12-30
(45)	Date of publication and mention of the grant of the patent	2011-05-25
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/EP2008/052960
	Date	2008-03-12

PCT application publication
(87)	Number	WO 2008/110579
	Date	2008-09-18

Priority applications
(30)	Number	Date	Country code
	200700665	2007-03-14	ES

Inventors
(72)	CASCALLO PIQUERAS, Manel Maria, ES GROS, Alena, ES ALEMANY BONASTRE, Ramon, ES

Grantee
(73)	Institut Catala D`Oncologia, Avenida Gran Via S/n Km. 2,7, 08907 L`Hospitalet de Llobregat, Barcelona, ES

Title
(54)	ADENOVIRUS WITH MUTATIONS IN THE ENDOPLASMIC RETICULUM RETENTION DOMAIN OF THE E3-19K PROTEIN AND THEIR USE IN CANCER TREATMENT.
	ADENOVIRUS WITH MUTATIONS IN THE ENDOPLASMIC RETICULUM RETENTION DOMAIN OF THE E3-19K PROTEIN AND THEIR USE IN CANCER TREATMENT.